Molecular Med Tri-Con 2020

Mar 1-4, San Francisco, CA

Short Course Session (SC10)

PuMA System


Microfluidics and Other Devices for POCT


Evan CromwellEvan F. Cromwell, PhD (President & CEO, Protein Fluidics, Inc.) will be one of the speakers during this session
Date: Mar 1, 2020, Sunday
Time: 5:30 – 8:30 pm
If you are interested in learning about the presentation contact us (Please mention Tri-Con in the comment box)

Tri-Con Event Details: click here

PuMA System 3D 

Cancer Drug Discovery
The PuMA System is an automated system designed to run assays using spheroids or organoids
for immunology, oncology, cellular stress, inflammation, and metabolic disease research.
 Pu•MA System 3D streamlines your workflow to automate assays with minimal user handling.
Learn more at our Pu•MA System page

Schedule a Meeting


By combining microfluidics and our proprietary design, we can help streamline your immuno- or 3D cell-based assays. 

Schedule a meeting during Tri-Con2020 for onsite discussion. 


Schedule a Meeting

Featured News

Jul 9, 2020 Protein Fluidics' Organoid Research Award: Prof. Matthew E. Burow & team (Tulane Univ)
Jan 25, 2020
Protein Fluidics launches Pu·MA System 3D for automated organoid assays
December 4, 2018
Protein Fluidics partners with BioLegend to provide Assay Products

May 4, 2018 Protein Fluidics announces the Pu·MA system
October 1, 2016 Protein Fluidics moves into new headquarters in Burlingame, CA
April 6, 2016 Protein Fluidics closes Series seed round of investment

For Research Use Only. Not for diagnostic use. Protein Fluidics, Protein Fluidics Logo and Pu•MA System are registered trademarks of Protein Fluidics, Inc. in the United States and internationally. All rights reserved. © 2020 PROTEIN FLUIDICS, INC.